Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Thaunat

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Transplant Immunology|November 24, 2011
Humoral immunity in chronic allograft rejection: puzzle pieces come togetherOlivier Thaunat
Nature Reviews. Nephrology|June 19, 2024
Natural killer cell-mediated innate microvascular rejectionOlivier Thaunat
Kidney International|December 10, 2015
Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppressionOlivier Thaunat
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Soothing touch of CD31 protects endothelium during cellular immune responsesOlivier Thaunat
Transplantation|May 11, 2011
Pathophysiologic significance of B-cell clusters in chronically rejected graftsOlivier Thaunat
Bulletin De L'Academie Nationale De Medecine|March 2, 2012
[Sterile inflammatory response to ischemia-reperfusion injury: immediate and long term consequences on graft function]Olivier Thaunat
Frontiers in Immunology|January 14, 2017
Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted OrgansAlice Koenig, Olivier Thaunat
Presse Medicale (Paris, France : 1983)|March 18, 2004
[Hepatic hydatidosis]Olivier Thaunat, Pascal Priollet
Nephrologie & Therapeutique|August 10, 2006
[Cancer and immunosuppression: pro- and antitumoral effects of immunosuppressive drugs]Olivier Thaunat, Emmanuel Morelon
Nature Reviews. Nephrology|March 31, 2016
Transplantation: BENEFIT of belatacept: kidney transplantation moves forwardMaarten Naesens, Olivier Thaunat
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Transplant Immunology|November 24, 2011
Humoral immunity in chronic allograft rejection: puzzle pieces come togetherOlivier Thaunat
Nature Reviews. Nephrology|June 19, 2024
Natural killer cell-mediated innate microvascular rejectionOlivier Thaunat
Kidney International|December 10, 2015
Finding the safe place between the hammer and the anvil: sounding the depth of therapeutic immunosuppressionOlivier Thaunat
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Soothing touch of CD31 protects endothelium during cellular immune responsesOlivier Thaunat
Transplantation|May 11, 2011
Pathophysiologic significance of B-cell clusters in chronically rejected graftsOlivier Thaunat
Bulletin De L'Academie Nationale De Medecine|March 2, 2012
[Sterile inflammatory response to ischemia-reperfusion injury: immediate and long term consequences on graft function]Olivier Thaunat
Frontiers in Immunology|January 14, 2017
Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted OrgansAlice Koenig, Olivier Thaunat
Presse Medicale (Paris, France : 1983)|March 18, 2004
[Hepatic hydatidosis]Olivier Thaunat, Pascal Priollet
Nephrologie & Therapeutique|August 10, 2006
[Cancer and immunosuppression: pro- and antitumoral effects of immunosuppressive drugs]Olivier Thaunat, Emmanuel Morelon
Nature Reviews. Nephrology|March 31, 2016
Transplantation: BENEFIT of belatacept: kidney transplantation moves forwardMaarten Naesens, Olivier Thaunat
Pageof 21